Related references
Note: Only part of the references are listed.Thoracic Neuroblastoma: A Novel Surgical Model for the Study of Extra-adrenal Neuroblastoma
Christa N. Grant et al.
IN VIVO (2022)
Arrested development: suppression of NK cell function in the tumor microenvironment
Luke Riggan et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)
The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology
Judith Wienke et al.
EUROPEAN JOURNAL OF CANCER (2021)
Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment
Feiya Ma et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs
Cristina Capuano et al.
CANCERS (2021)
Chemotherapy-Induced Upregulation of Small Extracellular Vesicle-Associated PTX3 Accelerates Breast Cancer Metastasis
Carson A. Wills et al.
CANCER RESEARCH (2021)
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
Joseph A. Flores-Toro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies
Dana L. Casey et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Tumor-Derived Exosomes in Immunosuppression and Immunotherapy
Wioletta Olejarz et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Bassel Nazha et al.
FRONTIERS IN ONCOLOGY (2020)
Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas
Mara Gilardi et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis
Andras Heczey et al.
NATURE MEDICINE (2020)
Immune characterization of pre-clinical murine models of neuroblastoma
Emily R. Webb et al.
SCIENTIFIC REPORTS (2020)
Antitumor activity without on-target off-tumor toxicity of GD2-chimeric antigen receptor T cells in patients with neuroblastoma
Karin Straathof et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
Ombretta Melaiu et al.
NATURE COMMUNICATIONS (2020)
Advances in the discovery of exosome inhibitors in cancer
Huarui Zhang et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
Irene Li et al.
MOLECULAR CANCER (2019)
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Mauro Poggio et al.
CELL (2019)
Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer
Jiangang Zhao et al.
CANCERS (2019)
VPS37A directs ESCRT recruitment for phagophore closure
Yoshinori Takahashi et al.
JOURNAL OF CELL BIOLOGY (2019)
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
Julie Voeller et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Structure and function of the immune system in the spleen
Steven M. Lewis et al.
SCIENCE IMMUNOLOGY (2019)
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma
Wesley E. Barry et al.
CLINICAL CANCER RESEARCH (2019)
High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer
Amrita Datta et al.
SCIENTIFIC REPORTS (2018)
CLEC10A Is a Specific Marker for Human CD1c+ Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine Secretion
Lukas Heger et al.
FRONTIERS IN IMMUNOLOGY (2018)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
A mechanistic classification of clinical phenotypes in neuroblastoma
Sandra Ackermann et al.
SCIENCE (2018)
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Clotilde Thery et al.
JOURNAL OF EXTRACELLULAR VESICLES (2018)
Anti-GD2 immunotherapy for neuroblastoma
Sameer Sait et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia
Chang-Sook Hong et al.
SCIENTIFIC REPORTS (2017)
Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF- and miR23a transfer
Guy Berchem et al.
ONCOIMMUNOLOGY (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents
Michiel Kroesen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
Thomas F. Eleveld et al.
NATURE GENETICS (2015)
Neuroblastoma Paradigm for Precision Medicine
Meredith S. Irwin et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2015)
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy
Mahiuddin Ahmed et al.
FEBS LETTERS (2014)
A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma
Michiel Kroesen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes
Francis H. W. Shand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
Shahab Asgharzadeh et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC
Christina Battke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
Kiavash Movahedi et al.
CANCER RESEARCH (2010)
Maturation of mouse NK cells is a 4-stage developmental program
Laura Chiossone et al.
BLOOD (2009)
The C-Type Lectin-Like Receptor CLEC-1, Expressed by Myeloid Cells and Endothelial Cells, Is Up-Regulated by Immunoregulatory Mediators and Moderates T Cell Activation
Pamela Thebault et al.
JOURNAL OF IMMUNOLOGY (2009)
Share Paper
